Therapeutics
Biotech• Unknown0
Summit Therapeutics
Market Cap
$13.38B
Stock Price
$0
SMMT
Corporate Profile
Summit Therapeutics stands as a titan in the Biotech sector. With a valuation of $13.38 Billion, the company employs over Unknown people worldwide. Headquartered in Unknown, it continues to drive innovation and maintain its market dominance.
Financial Performance
Revenue
--
Market Cap
$13.38B
Stock
$0